Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
- DOI
- 10.1200/jco.21.01805
- Published
- 2022 Jun 10
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco.21.01805,
title = {Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.},
author = {Carvajal RD and Nathan P and Sacco JJ and Orloff M and Hernandez-Aya LF and Yang J and Luke JJ and Butler MO and Stanhope S and Collins L and McAlpine C and Holland C and Abdullah SE and Sato T},
year = {2022},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco.21.01805},
url = {https://doi.org/10.1200/jco.21.01805}
}RIS
TY - JOUR TI - Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. AU - Carvajal RD AU - Nathan P AU - Sacco JJ AU - Orloff M AU - Hernandez-Aya LF AU - Yang J AU - Luke JJ AU - Butler MO AU - Stanhope S AU - Collins L AU - McAlpine C AU - Holland C AU - Abdullah SE AU - Sato T PY - 2022 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco.21.01805 UR - https://doi.org/10.1200/jco.21.01805 ER -
APA
RD, C., P, N., JJ, S., M, O., LF, H., J, Y., JJ, L., MO, B., S, S., L, C., C, M., C, H., SE, A., & T, S. (2022). Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.21.01805
Source records
- pubmed · retrieved 2026-09-26T01:00:29.332Z
- europe-pmc · retrieved 2026-09-26T01:00:29.342Z